Pharma Co. Sues K&L Gates Over Bungled Stock Offering

Law360, New York (May 1, 2013, 8:13 PM EDT) -- Pharmaceutical company Emmaus Medical Inc. on Tuesday hit K&L Gates LLP with a malpractice and breach of contract suit in California state court, alleging the firm botched its alternative public offering by playing both sides of the deal and withholding crucial information.

Emmaus says that after it entered into discussions with financial adviser AFH Holding & Advisory LLC and its managing director Amir Farrokh Heshmatpour about executing an APO using a reverse merger with an AFH-owned shell company, it retained K&L Gates and partner Thomas Poletti...
To view the full article, register now.